Prozac use for under 18s

The European Medicines Agency is recommending that selective serotonin re-uptake inhibitors (SSRIs) and serotonin noradrenaline re-uptake inhibitors (SNRIs) should not be used to treat children and adolescents unless authorised, because of the increased risk of suicide related behavior and hostility. It says that doctors should carefully monitor patients prescribed these drugs. UK regulators agreed with these guidelines with the exception of Prozac (Fluoxetine), however a final UK ruling is due in two to three months.

Nursing Times 3 May 2005 Vol 101 No 18